After nearly a decade building a prescription-based video game platform to help children with attention deficit hyperactivity disorder (ADHD), Akili Interactive Labs’s CEO Eddie Martucci said the company is making plans to market its software to US-based health care providers and patients in the new year.
EndeavorRx became the first prescription-only game-based device to be cleared for marketing by the US FDA under the de novo...